Abstract:Recent clinical observations suggest that viral infection/reactivation may contribute to the development of idiopathic pulmonary fibrosis in susceptible hosts. Viral gene therapy using adenoviral vectors in the lung is limited by immune response directed against the viral vector and/or its foreign gene. We therefore examined the effects of adenoviral vector (E1, E3 deleted) on the course of bleomycin-induced lung injury/fibrosis in mice.MethodsAdenoviral vectors (native and UV-inactivated) expressing luciferase, β-galactosidase, or a human gene were administered intratracheally (IT; 109 PFU/animal) to mice 2 days after bleomycin (4 U/kg IT). Animals were assessed for mortality, lung inflammation (bronchoalveolar lavage [BAL] cell counts and differential), vascular permeability (BAL protein levels) and fibrosis (lung hydroxyproline) over the next 28 days.ResultsCombined bleomycin/adenoviral vector administration caused a 3-fold increase in 28 day mortality compared with bleomycin alone (20% to 60%; n = 20/group). The excess mortality was completely abrogated by substituting a UV-inactivated vector and partially abrogated with a null-expressing adenoviral vector. Similarly, combined bleomycin/adenoviral vector administration caused a 2-fold increase in the increment of lung collagen (hydroxyproline) compared with bleomycin alone (150 ± 18 μg/animal vs 300 ± 22 μg/animal; n = 5/group), which was abrogated by substituting a UV-inactivated, or a null-expressing adenoviral vector. Neither IT adenoviral vectors alone nor IT saline alone induced lung fibrosis (by hydroxyproline and trichrome stain). Combined bleomycin/adenoviral vector administration also resulted in increased inflammation (2-fold increment in total BAL cells), and alveolar protein levels compared with bleomycin alone, at 10 days after IT bleomycin. Adenoviral vectors alone had no effect on BAL cell counts or protein levels compared with IT saline-administered controls. The alveolar lymphocytosis was also 2-fold higher in the bleomycin/adenovirally administered group compared with the bleomycin alone group. These data indicate that adenoviral vectors are proinflammatory, enhance lymphocytic recruitment into the alveolar compartment and profibrotic. Further, the dependence of these effects on viral/foreign gene expression implicate antiviral adaptive immunity. Viral-induced adaptive immunity may be one mechanism whereby viral infection will induce a fibrotic response in susceptible hosts with underlying lung inflammation.

Intratracheal gene transfer of decorin reduces subpleural fibroproliferation induced by bleomycin

Recombinant decorin ameliorates the pulmonary structure alterations by down-regulating transforming growth factor-β1Smads signaling in the diabetic rats

Inhalation of Itraconazole Mitigates Bleomycin-Induced Lung Fibrosis Via Regulating SPP1 and C3 Signaling Pathway Pivotal in the Interaction Between Phagocytic Macrophages and Diseased Fibroblasts

Gene Transfer of Vascular Endothelial Growth Factor Reduces Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits.

[The Effect of Murine Interferon-Gamma Transgene Expression on Bleomycin-Induced Pulmonary Fibrosis in Mice].

Effects of Murine Interferon-Γ Transgene Expression on Bleomycin-Induced Pulmonary Fibrosis in Mice at Different Stages

Adenovirus is Profibrotic in Bleomycin-Induced Lung Injury in Mice Through Effects on Adaptive Immunity.

The Mechanism of Treat Effect by the Transgenic Expression of Murine Interferon-Γ in Pulmonary Fibrosis Mouse.

Decorin Knockdown Affects The Gene Expression Profile Of Adhesion, Growth And Extracellular Matrix Metabolism In C-28/I2 Chondrocytes

Mir-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice

A Novel MyD88 Inhibitor Attenuates Allograft Rejection after Heterotopic Tracheal Transplantation in Mice

Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis

CREPT is Required for Pulmonary Fibrosis Induced by Bleomycin

Adenovirus-Mediated Decorin Gene Transfection Has Therapeutic Effects in A Streptozocin-Induced Diabetic Rat Model

Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice

Intratracheal therapy using nintedanib amorphous particles in murine pulmonary fibrosis

High endogenous activated protein C levels attenuates bleomycin-induced pulmonary fibrosis

Adenophorae Radix Reduces Fibrosis in a Bleomycin-Induced Pulmonary Fibrosis Mouse Model

Airway administration of dexamethasone, 3'-5'-cyclic adenosine monophosphate, and isobutylmethylxanthine facilitates compensatory lung growth in adult mice

A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans

Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis